Tezepelumab for chronic sinusitis with nasal polyps in Russia
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tracks how well tezepelumab works for people with chronic sinusitis and nasal polyps in real-world settings. It aims to see if this medication reduces symptoms and the need for surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need a diagnosis of chronic sinusitis with nasal polyps for at least 1 year.
- You must have medical records from the past year showing steroid use or nasal polyp surgery.
- You should have significant nasal blockage and moderate to severe sinus symptoms based on specific scoring.
- You cannot be pregnant, breastfeeding, or have any condition that makes tezepelumab unsafe for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients with chronic rhinosinusitis with nasal polyps (CRSwNP)—a condition causing blocked sinuses and nasal growths—who are starting a new biologic medication called tezepelumab. Researchers will track how symptoms and quality of life improve over time in everyday medical practice.
This trial tests a new biologic drug (tezepelumab) to see if it improves symptoms in people with both chronic sinusitis with nasal polyps and severe asthma. The goal is to reduce inflammation and help you breathe better. Participants must not have had prior sinus surgery.
This trial tests if Tezepelumab improves lung and sinus barrier function in people with severe asthma. It includes those who also have chronic sinusitis with nasal polyps, to see if the drug helps both conditions.
This study watches how well tezepelumab (Tezspire) works in real life for people who are already taking it for approved reasons. It collects information to make sure the medicine is safe and effective outside of a clinical trial.
This trial tests an injectable drug called TQC2731 for people with chronic sinusitis and nasal polyps that haven't been controlled well enough by standard treatments like steroid sprays or surgery. The goal is to see if it helps reduce nasal congestion, improve sense of smell, and shrink polyps.
This trial tests an investigational medication called AK139 for people with chronic sinusitis and nasal polyps. The treatment aims to reduce nasal congestion and polyp size, potentially improving symptoms.
Hear when a new Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.